Condition: MPS I · MPS II · MPS IVA · Sponsor: University of California, San Francisco
For detailed information, please view our study website: https://pearltrial.ucsf.edu/ The investigators aims to determine the the maternal and fetal safety and feasibility of in utero fetal enzyme replacement therapy in fetuses with Lysosomal Storage Diseases.
This description comes directly from the study's public registry record.
Tippi MacKenzie, MD · 415-476-4086 · tippi.mackenzie@ucsf.edu
Emma Canepa, MS, CCRP · 415-476-7255 · Emma.Canepa@ucsf.edu
Always discuss trial participation with your own doctor first.
| University of California | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04532047